- The performance of Ibrance will be crucial. Can robust revenue growth continue?
- Lyrica & Viagra sales need to remain strong in order to keep the company's sales stable while its blockbuster drugs catch up.
- Pfizer has taken on a sizeable amount of debt this year, so income investors should be watchful about dividend coverage.
The stock is basically trading flat for the year although it did reach the $37.30 level just before it announced its
Clinton's Policy Would Only Affect Companies With Generic Drugs
I think it's fair to say that many big pharmaceutical companies including Pfizer have suffered in recent months due to Hillary Clinton's posturing over excessive drug prices. Firstly, if she is elected, getting her plan through the Congress...